MAIA Biotechnology, Inc.
General ticker "MAIA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $46.3M (TTM average)
MAIA Biotechnology, Inc. does not follow the US Stock Market performance with the rate: -19.6%.
Estimated limits based on current volatility of 7.5%: low 1.10$, high 1.28$
Factors to consider:
- Total employees count: 13 (-27.8%) as of 2023
- Top business risk factors: Insufficient funding, Dependence on THIO, Limited operating history, Geopolitical risks, Licensing risks
- Current price 13.3% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.38$, 4.01$]
- 2025-12-31 to 2026-12-31 estimated range: [1.09$, 3.28$]
Financial Metrics affecting the MAIA estimates:
- Positive: with PPE of -2.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -35.22 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 35.79 <= 41.86
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
Short-term MAIA quotes
Long-term MAIA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $16.18MM | $20.18MM | $16.96MM |
| Operating Income | $-16.18MM | $-20.18MM | $-16.96MM |
| Non-Operating Income | $-0.22MM | $0.06MM | $-6.30MM |
| Interest Expense | $0.01MM | $0.01MM | $0.00MM |
| R&D Expense | $9.25MM | $11.29MM | $10.01MM |
| Income(Loss) | $-16.40MM | $-20.13MM | $-23.25MM |
| Profit(Loss)* | $-15.77MM | $-19.77MM | $-23.25MM |
| Stockholders Equity | $8.51MM | $0.48MM | $3.63MM |
| Assets | $12.02MM | $7.57MM | $10.16MM |
| Operating Cash Flow | $-12.10MM | $-13.07MM | $-15.70MM |
| Investing Cash Flow | $-0.00MM | $-0.00MM | $-0.02MM |
| Financing Cash Flow | $12.48MM | $9.27MM | $18.18MM |
| Earnings Per Share** | $-1.70 | $-1.49 | $-1.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.